SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001654954-24-001264
Filing Date
2024-02-02
Accepted
2024-02-02 21:30:45
Documents
2
Period of Report
2024-02-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT section16.html 4  
1 PRIMARY DOCUMENT section16.xml 4 7246
2 POWER OF ATTORNEY edesa-powerofattorneypard.htm EX-24 7938
  Complete submission text file 0001654954-24-001264.txt   16696
Mailing Address 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address 100 SPY COURT MARKHAM A6 L3R 5H6 (905) 475-1234
Edesa Biotech, Inc. (Issuer) CIK: 0001540159 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O EDESA BIOTECH INC. 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address
Nijhawan Pardeep (Reporting) CIK: 0001777962 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37619 | Film No.: 24593711